Taimed Biologics

ZIOPHARM Oncology is a biopharmaceutical company that focuses on the development and commercialization of a variety of cancer curing drugs. It conducts research and development studies, as well as performs clinical trials. The company has discovered Zymafos, a molecule that is the functional active metabolite of ifosfamide that is utilized in treating sarcoma and testicular cancer. It is also conducting various phases of clinical trials for Zinapar, which is an organic arsenic developed for the treatment of various types of hematological and solid cancers. ZIOPHARM Oncology additionally utilizes various biomarkers, as well as computer modeling and simulation technologies for performing clinical trial processes.

Alcon Manufacturing is responsible for the Custom-Pak surgical packs and other ophthalmic surgical disposables in the United States. It is a part of Alcon Laboratories, which was founded in 1945 and owned by Nestl . Alcon Laboratories has a staff of nearly 15,000 employees worldwide. The parent coapny develops, manufactures and distributes more than 100 eye care products in over180 countries. It was originated as a small pharmacy in the Southwest and has been operating for over 60 years. Alcon Laboratories is a part of Alcoa, which is one of the leaders in the production and management of primary and fabricated aluminum in the world. Alcoa serves the aerospace, automotive, packaging, building, construction, commercial transportation and industrial markets and also sells wheels, precision and investment castings, and fastening and building systems.

Biopharma Kiromic is a Houston-based company focused on revolutionizing cancer treatment through the development of immunotherapy drugs. With a technology pipeline managed by a team of experienced leaders and guided by a scientific advisory board, the company aims to address the high percentage of cancer deaths in the US that could potentially be treated with immunotherapy. However, the company acknowledges the challenges associated with immunotherapy, including poor response rates, toxicities, and off-target effects that can harm normal cells. At Biopharma Kiromic, cutting-edge research and development take place in state-of-the-art facilities and labs. The company is committed to advancing the field of immunotherapy through publications, presentations, and participation in industry events. With a focus on investor support, Biopharma Kiromic strives to make a significant impact in the fight against cancer.Generated from the website